ETLI.DE vs. EXV4.DE
ETLI.DE (L&G Pharma Breakthrough UCITS ETF) and EXV4.DE (iShares STOXX Europe 600 Health Care UCITS ETF (DE)) are both Health & Biotech Equities funds - ETLI.DE tracks the Solactive Pharma Breakthrough Value while EXV4.DE tracks the STOXX® Europe 600 Health Care. Both are passively managed. Over the past 5 years, ETLI.DE returned 2.31%/yr vs 4.98%/yr for EXV4.DE. A 0.60 correlation means they provide meaningful diversification when combined. ETLI.DE charges 0.49%/yr vs 0.46%/yr for EXV4.DE.
Performance
ETLI.DE vs. EXV4.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ETLI.DE achieves a -0.74% return, which is significantly higher than EXV4.DE's -2.60% return.
ETLI.DE
- 1D
- 2.62%
- 1M
- -3.54%
- YTD
- -0.74%
- 6M
- -2.98%
- 1Y
- 21.87%
- 3Y*
- 2.83%
- 5Y*
- 2.31%
- 10Y*
- —
EXV4.DE
- 1D
- 2.82%
- 1M
- 1.35%
- YTD
- -2.60%
- 6M
- -0.98%
- 1Y
- 4.83%
- 3Y*
- 2.32%
- 5Y*
- 4.98%
- 10Y*
- 5.78%
ETLI.DE vs. EXV4.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
ETLI.DE L&G Pharma Breakthrough UCITS ETF | -0.74% | 22.23% | 0.42% | -12.64% | -2.91% | 4.98% | 15.37% | 17.53% | -4.78% |
EXV4.DE iShares STOXX Europe 600 Health Care UCITS ETF (DE) | -2.60% | 7.23% | 3.85% | 7.52% | -6.10% | 25.12% | -2.48% | 32.64% | 3.47% |
Correlation
The correlation between ETLI.DE and EXV4.DE is 0.57, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.57 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.54 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.57 |
Correlation (All Time) Calculated using the full available price history since Feb 26, 2018 | 0.60 |
The correlation between ETLI.DE and EXV4.DE has been stable across timeframes, ranging from 0.54 to 0.60 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ETLI.DE vs. EXV4.DE — Risk / Return Rank
ETLI.DE
EXV4.DE
ETLI.DE vs. EXV4.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for L&G Pharma Breakthrough UCITS ETF (ETLI.DE) and iShares STOXX Europe 600 Health Care UCITS ETF (DE) (EXV4.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ETLI.DE | EXV4.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.87 | ||
| Sortino ratioReturn per unit of downside risk | +1.22 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 1.06 | +0.14 |
| Calmar ratioReturn relative to maximum drawdown | 2.40 | 0.38 | +2.02 |
| Martin ratioReturn relative to average drawdown | 6.79 | 0.84 | +5.95 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ETLI.DE | EXV4.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.16 | 0.29 | +0.87 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.13 | 0.32 | -0.18 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.37 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.22 | 0.32 | -0.10 |
Drawdowns
ETLI.DE vs. EXV4.DE - Drawdown Comparison
The maximum ETLI.DE drawdown since its inception was -30.83%, smaller than the maximum EXV4.DE drawdown of -44.54%. Use the drawdown chart below to compare losses from any high point for ETLI.DE and EXV4.DE.
Loading charts...
Drawdown Indicators
| ETLI.DE | EXV4.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -30.83% | -44.54% | +13.71% |
Max Drawdown (1Y)Largest decline over 1 year | -9.06% | -12.57% | +3.51% |
Max Drawdown (3Y)Largest decline over 3 years | -24.43% | -26.55% | +2.12% |
Max Drawdown (5Y)Largest decline over 5 years | -30.83% | -26.55% | -4.28% |
Max Drawdown (10Y)Largest decline over 10 years | — | -26.55% | — |
Current DrawdownCurrent decline from peak | -4.86% | -11.65% | +6.79% |
Average DrawdownAverage peak-to-trough decline | -10.22% | -11.17% | +0.95% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.21% | 5.72% | -2.51% |
Volatility
ETLI.DE vs. EXV4.DE - Volatility Comparison
L&G Pharma Breakthrough UCITS ETF (ETLI.DE) has a higher volatility of 6.89% compared to iShares STOXX Europe 600 Health Care UCITS ETF (DE) (EXV4.DE) at 5.58%. This indicates that ETLI.DE's price experiences larger fluctuations and is considered to be riskier than EXV4.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ETLI.DE | EXV4.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.89% | 5.58% | +1.31% |
Volatility (6M)Calculated over the trailing 6-month period | 14.09% | 11.86% | +2.23% |
Volatility (1Y)Calculated over the trailing 1-year period | 18.72% | 16.68% | +2.04% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.22% | 15.55% | +1.67% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.91% | 15.74% | +3.17% |
ETLI.DE vs. EXV4.DE - Expense Ratio Comparison
ETLI.DE has a 0.49% expense ratio, which is higher than EXV4.DE's 0.46% expense ratio.
Dividends
ETLI.DE vs. EXV4.DE - Dividend Comparison
ETLI.DE has not paid dividends to shareholders, while EXV4.DE's dividend yield for the trailing twelve months is around 1.61%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ETLI.DE L&G Pharma Breakthrough UCITS ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EXV4.DE iShares STOXX Europe 600 Health Care UCITS ETF (DE) | 1.61% | 1.58% | 1.45% | 1.60% | 1.59% | 1.47% | 1.24% | 1.79% | 1.85% | 2.64% | 2.90% | 2.60% |
Frequently Asked Questions
ETLI.DE and EXV4.DE have a correlation of 0.57, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, EXV4.DE is cheaper at 0.46% per year. The better choice depends on whether you care most about return, fees, risk, or income.
EXV4.DE is cheaper with a 0.46% expense ratio, compared with 0.49% for ETLI.DE.
ETLI.DE tracks Solactive Pharma Breakthrough Value, while EXV4.DE tracks STOXX® Europe 600 Health Care. They also come from different issuers: Legal & General and iShares. Their fees differ too: 0.49% for ETLI.DE and 0.46% for EXV4.DE.
Find the right allocation for ETLI.DE and EXV4.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer